Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1997 Oct;52(10):915–918. doi: 10.1136/thx.52.10.915

Erythromycin and diffuse panbronchiolitis

H Koyama, D M Geddes
PMCID: PMC1758435  PMID: 9404381

Full Text

The Full Text of this article is available as a PDF (93.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ashitani J., Doutsu Y., Ii T., Taniguchi H., Matsukura S. [A case of diffuse panbronchiolitis relieved rapidly by the treatment of roxithromycin]. Kansenshogaku Zasshi. 1992 May;66(5):657–658. doi: 10.11150/kansenshogakuzasshi1970.66.657. [DOI] [PubMed] [Google Scholar]
  2. Baz M. A., Kussin P. S., Van Trigt P., Davis R. D., Roggli V. L., Tapson V. F. Recurrence of diffuse panbronchiolitis after lung transplantation. Am J Respir Crit Care Med. 1995 Mar;151(3 Pt 1):895–898. doi: 10.1164/ajrccm/151.3_Pt_1.895. [DOI] [PubMed] [Google Scholar]
  3. Brugiere O., Milleron B., Antoine M., Carette M. F., Philippe C., Mayaud C. Diffuse panbronchiolitis in an Asian immigrant. Thorax. 1996 Oct;51(10):1065–1067. doi: 10.1136/thx.51.10.1065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Danbara T., Matsuoka R., Nukiwa T., Natori H., Arai T., Kira S. [Familial occurrence of diffuse panbronchiolitis accompanied with elevation of cold agglutinin titer in a father and his two daughters]. Nihon Kyobu Shikkan Gakkai Zasshi. 1982 May;20(5):597–603. [PubMed] [Google Scholar]
  5. Fitzgerald J. E., King T. E., Jr, Lynch D. A., Tuder R. M., Schwarz M. I. Diffuse panbronchiolitis in the United States. Am J Respir Crit Care Med. 1996 Aug;154(2 Pt 1):497–503. doi: 10.1164/ajrccm.154.2.8756828. [DOI] [PubMed] [Google Scholar]
  6. Fujii T., Kadota J., Kawakami K., Iida K., Shirai R., Kaseda M., Kawamoto S., Kohno S. Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection. Thorax. 1995 Dec;50(12):1246–1252. doi: 10.1136/thx.50.12.1246. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Goswami S. K., Kivity S., Marom Z. Erythromycin inhibits respiratory glycoconjugate secretion from human airways in vitro. Am Rev Respir Dis. 1990 Jan;141(1):72–78. doi: 10.1164/ajrccm/141.1.72. [DOI] [PubMed] [Google Scholar]
  8. Homer R. J., Khoo L., Smith G. J. Diffuse panbronchiolitis in a Hispanic man with travel history to Japan. Chest. 1995 Apr;107(4):1176–1178. doi: 10.1378/chest.107.4.1176. [DOI] [PubMed] [Google Scholar]
  9. Ichikawa Y., Ninomiya H., Koga H., Tanaka M., Kinoshita M., Tokunaga N., Yano T., Oizumi K. Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients. Am Rev Respir Dis. 1992 Jul;146(1):196–203. doi: 10.1164/ajrccm/146.1.196. [DOI] [PubMed] [Google Scholar]
  10. Iwata M., Colby T. V., Kitaichi M. Diffuse panbronchiolitis: diagnosis and distinction from various pulmonary diseases with centrilobular interstitial foam cell accumulations. Hum Pathol. 1994 Apr;25(4):357–363. doi: 10.1016/0046-8177(94)90143-0. [DOI] [PubMed] [Google Scholar]
  11. Izumi T. Diffuse panbronchiolitis. Chest. 1991 Sep;100(3):596–597. doi: 10.1378/chest.100.3.596. [DOI] [PubMed] [Google Scholar]
  12. Izumi T. [Japanese clinical statistical data of patients with diffuse panbronchiolitis]. Nihon Rinsho. 1992 Nov;50 (Suppl):386–394. [PubMed] [Google Scholar]
  13. Kadota J., Matsubara Y., Ishimatsu Y., Ashida M., Abe K., Shirai R., Iida K., Kawakami K., Taniguchi H., Fujii T. Significance of IL-1beta and IL-1 receptor antagonist (IL-1Ra) in bronchoalveolar lavage fluid (BALF) in patients with diffuse panbronchiolitis (DPB). Clin Exp Immunol. 1996 Mar;103(3):461–466. doi: 10.1111/j.1365-2249.1996.tb08303.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kadota J., Oda H., Sakito O., Sawa H., Morikawa N., Mukae H., Senju R., Tomono K., Fukushima K., Hiratani K. [Effect of erythromycin on neutrophil function in chronic respiratory tract diseases with Pseudomonas infection]. Kansenshogaku Zasshi. 1991 Mar;65(3):277–285. doi: 10.11150/kansenshogakuzasshi1970.65.277. [DOI] [PubMed] [Google Scholar]
  15. Kadota J., Sakito O., Kohno S., Sawa H., Mukae H., Oda H., Kawakami K., Fukushima K., Hiratani K., Hara K. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis. 1993 Jan;147(1):153–159. doi: 10.1164/ajrccm/147.1.153. [DOI] [PubMed] [Google Scholar]
  16. Keicho N., Kudoh S., Yotsumoto H., Akagawa K. S. Antilymphocytic activity of erythromycin distinct from that of FK506 or cyclosporin A. J Antibiot (Tokyo) 1993 Sep;46(9):1406–1413. doi: 10.7164/antibiotics.46.1406. [DOI] [PubMed] [Google Scholar]
  17. Koyama H., Nishimura K., Mio T., Ikeda A., Sugiura N., Izumi T. Bronchial responsiveness and acute bronchodilator response in chronic obstructive pulmonary disease and diffuse panbronchiolitis. Thorax. 1994 Jun;49(6):540–544. doi: 10.1136/thx.49.6.540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kudoh S., Uetake T., Hagiwara K., Hirayama M., Hus L. H., Kimura H., Sugiyama Y. [Clinical effects of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis]. Nihon Kyobu Shikkan Gakkai Zasshi. 1987 Jun;25(6):632–642. [PubMed] [Google Scholar]
  19. Masutani T., Sawaki M., Mikasa K., Konishi M., Yagyu Y., Narita N., Harikane O., Sano R., Munekawa Y., Mase T. [Inhibitory effect of erythromycin on elastase producing ability of Pseudomonas aeruginosa]. Kansenshogaku Zasshi. 1989 Oct;63(10):1212–1214. doi: 10.11150/kansenshogakuzasshi1970.63.1212. [DOI] [PubMed] [Google Scholar]
  20. Mikasa K., Sawaki M., Konishi M., Egawa S., Yoneda T., Yagyu Y., Fujimura M., Hamada K., Kunimatsu M., Narita N. [The effect of erythromycin treatment on natural killer (NK) cell activity in patients with chronic lower respiratory tract infections]. Kansenshogaku Zasshi. 1989 Aug;63(8):811–815. doi: 10.11150/kansenshogakuzasshi1970.63.811. [DOI] [PubMed] [Google Scholar]
  21. Mukae H., Ashitani J., Nakazato M., Taniguchi H., Date Y., Ihi T., Shiomi K., Mashimoto H., Kadota J., Kohno S. [A study of defensins in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis]. Kansenshogaku Zasshi. 1995 Sep;69(9):975–981. doi: 10.11150/kansenshogakuzasshi1970.69.975. [DOI] [PubMed] [Google Scholar]
  22. Mukae H., Kadota J., Kohno S., Kusano S., Morikawa T., Matsukura S., Hara K. Increase in activated CD8+ cells in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis. Am J Respir Crit Care Med. 1995 Aug;152(2):613–618. doi: 10.1164/ajrccm.152.2.7633715. [DOI] [PubMed] [Google Scholar]
  23. Nagai H., Shishido H., Yoneda R., Yamaguchi E., Tamura A., Kurashima A. Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis. Respiration. 1991;58(3-4):145–149. doi: 10.1159/000195915. [DOI] [PubMed] [Google Scholar]
  24. Nishimura K., Kitaichi M., Izumi T., Itoh H. Diffuse panbronchiolitis: correlation of high-resolution CT and pathologic findings. Radiology. 1992 Sep;184(3):779–785. doi: 10.1148/radiology.184.3.1509067. [DOI] [PubMed] [Google Scholar]
  25. Oda H., Kadota J., Kohno S., Hara K. Leukotriene B4 in bronchoalveolar lavage fluid of patients with diffuse panbronchiolitis. Chest. 1995 Jul;108(1):116–122. doi: 10.1378/chest.108.1.116. [DOI] [PubMed] [Google Scholar]
  26. Ohno S., Sugiyama Y., Kitamura S. [Clinical effects of low-dose and long-term erythromycin in diffuse panbronchiolitis with chronic respiratory failure]. Nihon Kyobu Shikkan Gakkai Zasshi. 1993 Oct;31(10):1251–1256. [PubMed] [Google Scholar]
  27. Oishi K., Sonoda F., Kobayashi S., Iwagaki A., Nagatake T., Matsushima K., Matsumoto K. Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases. Infect Immun. 1994 Oct;62(10):4145–4152. doi: 10.1128/iai.62.10.4145-4152.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Poletti V., Patelli M., Poletti G., Bertanti T., Spiga L. Diffuse panbronchiolitis observed in an Italian. Chest. 1990 Aug;98(2):515–516. doi: 10.1378/chest.98.2.515. [DOI] [PubMed] [Google Scholar]
  29. Roche Y., Gougerot-Pocidalo M. A., Fay M., Forest N., Pocidalo J. J. Macrolides and immunity: effects of erythromycin and spiramycin on human mononuclear cell proliferation. J Antimicrob Chemother. 1986 Feb;17(2):195–203. doi: 10.1093/jac/17.2.195. [DOI] [PubMed] [Google Scholar]
  30. Sakata K., Yajima H., Tanaka K., Sakamoto Y., Yamamoto K., Yoshida A., Dohi Y. Erythromycin inhibits the production of elastase by Pseudomonas aeruginosa without affecting its proliferation in vitro. Am Rev Respir Dis. 1993 Oct;148(4 Pt 1):1061–1065. doi: 10.1164/ajrccm/148.4_Pt_1.1061. [DOI] [PubMed] [Google Scholar]
  31. Sawaki M., Mikami R., Mikasa K., Kunimatsu M., Ito S., Narita N. [The long term chemotherapy with erythromycin in chronic lower respiratory tract infections--first report: comparison with amoxicillin]. Kansenshogaku Zasshi. 1986 Jan;60(1):37–44. doi: 10.11150/kansenshogakuzasshi1970.60.37. [DOI] [PubMed] [Google Scholar]
  32. Sawaki M., Mikami R., Mikasa K., Kunimatsu M., Ito S., Narita N. [The long term chemotherapy with erythromycin in chronic lower respiratory tract infections--second report: including cases with Pseudomonas infections]. Kansenshogaku Zasshi. 1986 Jan;60(1):45–50. doi: 10.11150/kansenshogakuzasshi1970.60.45. [DOI] [PubMed] [Google Scholar]
  33. Sugiyama Y., Kudoh S., Maeda H., Suzaki H., Takaku F. Analysis of HLA antigens in patients with diffuse panbronchiolitis. Am Rev Respir Dis. 1990 Jun;141(6):1459–1462. doi: 10.1164/ajrccm/141.6.1459. [DOI] [PubMed] [Google Scholar]
  34. Sugiyama Y., Sugama Y., Takeuchi K., Kudoh S., Kitamura S. [Analysis of peripheral lymphocyte subsets and changes due to erythromycin therapy in patients with diffuse panbronchiolitis]. Nihon Kyobu Shikkan Gakkai Zasshi. 1990 Dec;28(12):1574–1580. [PubMed] [Google Scholar]
  35. Takeda H., Miura H., Kawahira M., Kobayashi H., Otomo S., Nakaike S. [Long-term administration study on TE-031 (A-56268) in the treatment of diffuse panbronchiolitis]. Kansenshogaku Zasshi. 1989 Jan;63(1):71–78. doi: 10.11150/kansenshogakuzasshi1970.63.71. [DOI] [PubMed] [Google Scholar]
  36. Takeda H., Oogaki N., Kikuchi N., Kobayashi H., Akashi T. [A study to clarify the mechanism of the usefulness of the macrolides--the influence of clarithromycin to biofilm with P. aeruginosa]. Kansenshogaku Zasshi. 1992 Oct;66(10):1454–1461. doi: 10.11150/kansenshogakuzasshi1970.66.1454. [DOI] [PubMed] [Google Scholar]
  37. Tamaoki J., Isono K., Sakai N., Kanemura T., Konno K. Erythromycin inhibits Cl secretion across canine tracheal epithelial cells. Eur Respir J. 1992 Feb;5(2):234–238. [PubMed] [Google Scholar]
  38. Tamaoki J., Nakata J., Takeda Y., Takemura H., Tagaya E., Konno K. [Effect of macrolide antibiotics on airway goblet hypersecretion in guinea pigs]. Kansenshogaku Zasshi. 1996 Jun;70(6):591–596. doi: 10.11150/kansenshogakuzasshi1970.70.591. [DOI] [PubMed] [Google Scholar]
  39. Tredaniel J., Zalcman G., Gerber F., D'Agay M. F., Capron F., Frija J., Hirsch A. Diffuse panbronchiolitis: efficacy of low-dose erythromycin. Respir Med. 1993 Apr;87(3):229–230. doi: 10.1016/0954-6111(93)90099-l. [DOI] [PubMed] [Google Scholar]
  40. Van Dis M. L. "Doctor, I've got the TMJ!". Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996 Dec;82(6):591–591. doi: 10.1016/s1079-2104(96)80429-x. [DOI] [PubMed] [Google Scholar]
  41. Yasuda H., Ajiki Y., Koga T., Kawada H., Yokota T. Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin. Antimicrob Agents Chemother. 1993 Sep;37(9):1749–1755. doi: 10.1128/aac.37.9.1749. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES